Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rilpivirine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06403865
What this trial is testing

Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine

Who this might be right for
Quality of Life
University Paris 7 - Denis Diderot 280
Large-scale testing (Phase 3)Ended earlyNCT03563742
What this trial is testing

Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Who this might be right for
Human Immunodeficiency Virus Infections
Janssen Research & Development, LLC 58
Not applicableLooking for participantsNCT07727642
What this trial is testing

Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma

Who this might be right for
AIDS-related LymphomaHIV Infection
Shanghai Public Health Clinical Center 60
Post-approval studies (Phase 4)Looking for participantsNCT06646562
What this trial is testing

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Who this might be right for
HIV-1 Infected Adults with Controlled Viremia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 120
Not applicableStudy completedNCT04973254
What this trial is testing

Improving Treatment and Retention Adherence in Nontraditional Settings

Who this might be right for
HIV Infections
Boston Medical Center 25
Not applicableStudy completedNCT05152953
What this trial is testing

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Who this might be right for
Hiv
University of California, San Francisco 63
Large-scale testing (Phase 3)Study completedNCT04542070
What this trial is testing

Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed

Who this might be right for
HIV Infections
ViiV Healthcare 687
Post-approval studies (Phase 4)Study completedNCT01804244
What this trial is testing

A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Not applicableActive Not RecruitingNCT06518408
What this trial is testing

A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

Who this might be right for
Human Immunodeficiency Virus
University Hospital Virgen de las Nieves 287
Early research (Phase 1)Study completedNCT01719614
What this trial is testing

Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants

Who this might be right for
Healthy Participants
Janssen R&D Ireland 20
Not applicableActive Not RecruitingNCT07703748
What this trial is testing

Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.

Who this might be right for
Human Immunodeficiency Virus Infection (HIV)HIV-1 Infection in Adults
FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE 3,346
Early research (Phase 1)Study completedNCT01656018
What this trial is testing

Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 4
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Testing effectiveness (Phase 2)WithdrawnNCT06336434
What this trial is testing

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Who this might be right for
HIV-1-infectionPregnancyPostpartum
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Study completedNCT01585038
What this trial is testing

Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress

Who this might be right for
Cardiovascular Disease
Indiana University 40
Not applicableActive Not RecruitingNCT06468995
What this trial is testing

Antiviral Long Acting Drugs Landing in People Living With HIV

Who this might be right for
HIVAntiviral Agents
IRCCS San Raffaele 120
Testing effectiveness (Phase 2)Study completedNCT02165202
What this trial is testing

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

Who this might be right for
Human Immunodeficiency Virus (HIV)
PATH 136
Large-scale testing (Phase 3)Study completedNCT02429791
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)

Who this might be right for
HIV Infections
ViiV Healthcare 510
Early research (Phase 1)Looking for participantsNCT05418868
What this trial is testing

Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 214
Large-scale testing (Phase 3)Study completedNCT01792570
What this trial is testing

DRV/r + RPV QD: Efficacy and Toxicity Reduction

Who this might be right for
Human Immunodeficiency Virus
ASST Fatebenefratelli Sacco 37
Next Page